| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A multi-antigen vaccine in combination with an immunotoxin targeting tumor-associated fibroblast for treating murine melanoma
|
Fang, Jinxu
|
|
2016
|
3 |
C |
p. -
1 p.
|
artikel
|
| 2 |
An MHC-restricted antibody-based chimeric antigen receptor requires TCR-like affinity to maintain antigen specificity
|
Maus, Marcela V
|
|
2016
|
3 |
C |
p. -
1 p.
|
artikel
|
| 3 |
A novel, polymer-coated oncolytic measles virus overcomes immune suppression and induces robust antitumor activity
|
Nosaki, Kaname
|
|
2016
|
3 |
C |
p. -
1 p.
|
artikel
|
| 4 |
Application of interferon modulators to overcome partial resistance of human ovarian cancers to VSV-GP oncolytic viral therapy
|
Dold, Catherine
|
|
2016
|
3 |
C |
p. -
1 p.
|
artikel
|
| 5 |
Augmentation of cellular and humoral immune responses to HPV16 and HPV18 E6 and E7 antigens by VGX-3100
|
Morrow, Matthew P
|
|
2016
|
3 |
C |
p. -
1 p.
|
artikel
|
| 6 |
CAR models: next-generation CAR modifications for enhanced T-cell function
|
Abate-Daga, Daniel
|
|
2016
|
3 |
C |
p. -
1 p.
|
artikel
|
| 7 |
CD19xCD3 DART protein mediates human B-cell depletion in vivo in humanized BLT mice
|
Tsai, Perry
|
|
2016
|
3 |
C |
p. -
1 p.
|
artikel
|
| 8 |
Chimeric antigen receptor T-cell therapy for solid tumors
|
Newick, Kheng
|
|
2016
|
3 |
C |
p. -
1 p.
|
artikel
|
| 9 |
Clinical manufacturing of CAR T cells: foundation of a promising therapy
|
Wang, Xiuyan
|
|
2016
|
3 |
C |
p. -
1 p.
|
artikel
|
| 10 |
Complement inhibition enables tumor delivery of LCMV glycoprotein pseudotyped viruses in the presence of antiviral antibodies
|
Evgin, Laura
|
|
2016
|
3 |
C |
p. -
1 p.
|
artikel
|
| 11 |
Curcumin inhibited HGF-induced EMT and angiogenesis through regulating c-Met dependent PI3K/Akt/mTOR signaling pathways in lung cancer
|
Jiao, Demin
|
|
2016
|
3 |
C |
p. -
1 p.
|
artikel
|
| 12 |
Design and characterization of the tumor vaccine MGN1601, allogeneic fourfold gene-modified vaccine cells combined with a TLR-9 agonist
|
Volz, Barbara
|
|
2016
|
3 |
C |
p. -
1 p.
|
artikel
|
| 13 |
Development of new therapy for canine mammary cancer with recombinant measles virus
|
Shoji, Koichiro
|
|
2016
|
3 |
C |
p. -
1 p.
|
artikel
|
| 14 |
Enhanced lysis by bispecific oncolytic measles viruses simultaneously using HER2/neu or EpCAM as target receptors
|
Hanauer, Jan RH
|
|
2016
|
3 |
C |
p. -
1 p.
|
artikel
|
| 15 |
Evaluation of polymer shielding for adenovirus serotype 6 (Ad6) for systemic virotherapy against human prostate cancers
|
Nguyen, Tien V
|
|
2016
|
3 |
C |
p. -
1 p.
|
artikel
|
| 16 |
Expression of DAI by an oncolytic vaccinia virus boosts the immunogenicity of the virus and enhances antitumor immunity
|
Hirvinen, Mari
|
|
2016
|
3 |
C |
p. -
1 p.
|
artikel
|
| 17 |
Genetic engineering of chimeric antigen receptors using lamprey derived variable lymphocyte receptors
|
Moot, Robert
|
|
2016
|
3 |
C |
p. -
1 p.
|
artikel
|
| 18 |
High-content molecular profiling of T-cell therapy in oncology
|
Novosiadly, Ruslan
|
|
2016
|
3 |
C |
p. -
1 p.
|
artikel
|
| 19 |
Immunogenicity of self tumor associated proteins is enhanced through protein truncation
|
Kottke, Tim
|
|
2016
|
3 |
C |
p. -
1 p.
|
artikel
|
| 20 |
Immunological quality and performance of tumor vessel-targeting CAR-T cells prepared by mRNA-EP for clinical research
|
Inoo, Kanako
|
|
2016
|
3 |
C |
p. -
1 p.
|
artikel
|
| 21 |
LV305, a dendritic cell-targeting integration-deficient ZVexTM-based lentiviral vector encoding NY-ESO-1, induces potent anti-tumor immune response
|
Albershardt, Tina Chang
|
|
2016
|
3 |
C |
p. -
1 p.
|
artikel
|
| 22 |
Molecular network, pathway, and functional analysis of time-dependent gene changes associated with pancreatic cancer susceptibility to oncolytic vaccinia virotherapy
|
Haddad, Dana
|
|
2016
|
3 |
C |
p. -
1 p.
|
artikel
|
| 23 |
N-end rule pathway inhibition assists colon tumor regression via necroptosis
|
Agarwalla, Pritha
|
|
2016
|
3 |
C |
p. -
1 p.
|
artikel
|
| 24 |
Next frontiers in CAR T-cell therapy
|
Brown, Christine E
|
|
2016
|
3 |
C |
p. -
1 p.
|
artikel
|
| 25 |
N-Myc expression enhances the oncolytic effects of vesicular stomatitis virus in human neuroblastoma cells
|
Corredor, Juan C
|
|
2016
|
3 |
C |
p. -
1 p.
|
artikel
|
| 26 |
Oncolytic herpes simplex virus kills stem-like tumor-initiating colon cancer cells
|
Warner, Susanne G
|
|
2016
|
3 |
C |
p. -
1 p.
|
artikel
|
| 27 |
Oncolytic vesicular stomatitis virus expressing interferon-σ has enhanced therapeutic activity
|
Bourgeois-Daigneault, Marie-Claude
|
|
2016
|
3 |
C |
p. -
1 p.
|
artikel
|
| 28 |
Oncolytic viruses on the cusp of success?: proceedings of the 9th International Conference on Oncolytic Virus Therapeutics
|
Peters, Cole
|
|
2016
|
3 |
C |
p. -
1 p.
|
artikel
|
| 29 |
Poly-functional and long-lasting anticancer immune response elicited by a safe attenuated Pseudomonas aeruginosa vector for antigens delivery
|
Chauchet, Xavier
|
|
2016
|
3 |
C |
p. -
1 p.
|
artikel
|
| 30 |
Preclinical evaluation of VAX-IP, a novel bacterial minicell-based biopharmaceutical for nonmuscle invasive bladder cancer
|
Tsuji, Shingo
|
|
2016
|
3 |
C |
p. -
1 p.
|
artikel
|
| 31 |
Recombinant mumps virus as a cancer therapeutic agent
|
Ammayappan, Arun
|
|
2016
|
3 |
C |
p. -
1 p.
|
artikel
|
| 32 |
Reprogramming antitumor immunity against chemoresistant ovarian cancer by a CXCR4 antagonist-armed viral oncotherapy
|
Komorowski, Marcin P
|
|
2016
|
3 |
C |
p. -
1 p.
|
artikel
|
| 33 |
Systemically administered AAV9-sTRAIL combats invasive glioblastoma in a patient-derived orthotopic xenograft model
|
Crommentuijn, Matheus HW
|
|
2016
|
3 |
C |
p. -
1 p.
|
artikel
|
| 34 |
Systemic therapy with oncolytic myxoma virus cures established residual multiple myeloma in mice
|
Bartee, Eric
|
|
2016
|
3 |
C |
p. -
1 p.
|
artikel
|
| 35 |
Toxicity and management in CAR T-cell therapy
|
Bonifant, Challice L
|
|
2016
|
3 |
C |
p. -
1 p.
|
artikel
|
| 36 |
Tumor control by human cytomegalovirus in a murine model of hepatocellular carcinoma
|
Kumar, Amit
|
|
2016
|
3 |
C |
p. -
1 p.
|
artikel
|
| 37 |
Tunneling nanotubes: an alternate route for propagation of the bystander effect following oncolytic viral infection
|
Ady, Justin
|
|
2016
|
3 |
C |
p. -
1 p.
|
artikel
|
| 38 |
Whole cell vaccination using immunogenic cell death by an oncolytic adenovirus is effective against a colorectal cancer model
|
Yamano, Tomoki
|
|
2016
|
3 |
C |
p. -
1 p.
|
artikel
|
Tijdschrift beschrijving